PPTA | Immunoglobulin Literature Database
Home
Contact us
- - - - - - -
News/archive
Literature database
Cardiology
Dermatology
Guidelines
Haematology
Infectious Diseases
Internal Medicine
Neonatology
Nephrology
Neurology
Obstetrics
Paediatrics
Pulmonology
Rheumatology
Miscellaneous
PID
Guillain-Barré syndrome
Title Filter
Display #
5
10
15
20
25
30
50
100
All
#
Article Title
1
Emerging drugs for Guillain-Barre syndrome.
2
Plasma exchange after initial intravenous immunoglobulin treatment in guillain-barré syndrome: critical reassessment of effectiveness and cost-efficiency.
3
[Current use of immunoglobulins in neurology :]
4
Prominent plasmacytosis following intravenous immunoglobulin correlates with clinical improvement in
5
[High-dose intravenous immunoglobulins for treatment of optic neuritis in Guillain-Barré syndrome]
6
Motor recovery after Guillain-Barré syndrome in childhood.
7
Pharmacoeconomics of therapy for Guillain-Barre syndrome: plasma exchange and intravenous immunoglob
8
Guidelines on the use of intravenous immune globulin for neurologic conditions.
9
Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders.
10
Drug Insight: the use of intravenous immunoglobulin in neurology-therapeutic considerations and prac
11
Guillain-Barre syndrome.
12
Current therapeutic options in severe Guillain-Barre syndrome.
13
Current therapeutic options in severe guillain-barre syndrome.
14
[High doses of immunoglobulin G in the therapy for severe forms of myasthenia gravis and Guillain-Ba
15
Guillain-Barre syndrome in the elderly: clinical, electrophysiological, therapeutic and outcome feat
16
Posttransplant guillain barre syndrome
17
[Present treatment of Guillain-Barre syndrome]
18
Use of IV immunoglobulins in neurology. Evidence-based consensus
19
Immunoglobulin improves a model of acute motor axonal neuropathy by preventing axonal degeneration.
20
Treatment of inflammatory and paraproteinemic neuropathies.
<<
Start
<
Prev
1
2
Next
>
End
>>
Page 1 of 2
FIND-ID
Regulators
FDA
EMEA